News

FDA commissioner stirs debate over hormone therapy for menopause
A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...
BioPharma Dive4h
FDA delays approval decision for Bayer menopause therapy
The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...
BizPac Review3d
‘All of us are begging’: New push for FDA to remove ‘black box’ warnings from menopause products
The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...
How one controversial study shaped 20 years of menopause care
Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...
The Manila Times4d
Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
A first-of-its-kind solution for women’s arousal - the same active ingredient as in Viagra® for men - in a proprietary ...
Bayer's elinzanetant review period gets extended by FDA
Bayer announced an FDA review extension for Elinzanetant, its experimental menopausal hot flash therapy. Approval remains on track. REad more here.
Everyday Health on MSN3d
New FDA Panel Recommends Removing Warnings From Estrogen Therapies for Menopause
The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who ...
Black box warning on menopause hormone therapies should be removed, experts say
All menopause treatments containing the hormone estrogen are mandated by the US Food and Drug Administration to carry a black ...